Printer Friendly

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019.

NEW YORK, Sept. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

http://www.reportlinker.com/p0548322/Obsessive-Compulsive-Disorder-OCD-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, "Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Obsessive Compulsive Disorder Therapeutics market. The report identifies the key trends shaping and driving the global Obsessive Compulsive Disorder Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Obsessive Compulsive Disorder Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Obsessive Compulsive Disorder Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Obsessive Compulsive Disorder Therapeutics market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Obsessive-Compulsive Disorder Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Obsessive Compulsive Disorder Therapeutics market

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Obsessive Compulsive Disorder Therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Obsessive Compulsive Disorder Therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global Obsessive Compulsive Disorder Therapeutics market landscape? - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Obsessive Compulsive Disorder Therapeutics - Introduction 7

2.1 Disease Overview 7

2.1.1 Mild Obsessive Compulsive Disorder 7

2.1.2 Moderate Obsessive Compulsive Disorder 7

2.1.3 Severe Obsessive Compulsive Disorder 7

2.2 Epidemiology 8

2.2.1 Prevalence 8

2.2.2 Quality of Life Parameters 9

2.3 Etiology and Pathophysiology 9

2.3.1 Seretonin Hypothesis 9

2.3.2 Dopamine Hypothesis 10

2.3.3 Genetics 11

2.3.4 Autoimmune 11

2.4 Obsessive Compulsive Disorder Signs and Symptoms 11

2.4.1 Obsessive Thoughts 11

2.4.2 Compulsive Behaviors 11

2.5 Diagnosis 12

2.5.1 Diagnostic Criteria for Obsessive Compulsive Disorder Defined by DSM-IV 12

2.5.2 Measurement Scales 13

2.6 Treatment and Management Options 14

2.6.1 Psychological Treatment 15

2.6.2 Pharmacologic Treatment 15

2.6.3 Combination Treatment 16

2.7 Referral Pathway 16

2.8 GlobalData Pipeline Report Guidance 18

3 Obsessive Compulsive Disorder Therapeutics - Market Characterization 19

3.1 Overview 19

3.2 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - Global 19

3.3 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Global 20

3.4 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - The US 21

3.5 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - The US 22

3.6 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - France 23

3.7 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - France 24

3.8 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - Germany 25

3.9 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Germany 26

3.10 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - Italy 27

3.11 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Italy 28

3.12 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - Spain 29

3.13 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Spain 30

3.14 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - The UK 31

3.15 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - The UK 32

3.16 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) - Japan 33

3.17 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Japan 34

3.18 Drivers and Barriers for the Obsessive Compulsive Disorder Therapeutics Market 35

3.18.1 Drivers for the Obsessive Compulsive Disorder Therapeutics Market 35

3.18.2 Barriers for the Obsessive Compulsive Disorder Therapeutics Market 35

3.19 Opportunity and Unmet Need Analysis 35

3.20 Key Takeaway 37

4 Obsessive Compulsive Disorder Therapeutics - Competitive Assessment 38

4.1 Overview 38

4.2 Strategic Competitor Assessment 38

4.3 Product Profiles for the Major Marketed Products in the Obsessive Compulsive Disorder Therapeutics Market 40

4.3.1 Paroxetine hydrochloride 40

4.3.2 Sertraline hydrochloride 41

4.3.3 Fluvoxamine maleate 42

4.3.4 Fluoxetine hydrochloride 43

4.3.5 Clomipramine hydrochloride 44

4.4 Key Takeaway 45

5 Obsessive Compulsive Disorder Therapeutics - Pipeline Assessment 46

5.1 Overview 46

5.2 Strategic Pipeline Assessment 46

5.3 Obsessive Compulsive Disorder Therapeutics Pipeline - Pipeline by Phases of Development 47

5.3.1 Obsessive Compulsive Disorder Therapeutics - Phase III Pipeline 47

5.3.2 Obsessive Compulsive Disorder Therapeutics - Phase II Pipeline 47

5.3.3 Obsessive Compulsive Disorder Therapeutics - Pre-Clinical Pipeline 48

5.3.4 Obsessive Compulsive Disorder Therapeutics -Discovery Pipeline 48

5.3.5 Technology Trends Analytic Framework 49

5.4 Obsessive Compulsive Disorder Therapeutics Market -Pipeline by Mechanism of Action 51

5.5 Molecule Profile for Promising Drugs under Clinical Development 52

5.5.1 Gamunex 52

5.5.2 TO-2061 (ondansetron) 53

5.6 Key Takeaway 53

6 Obsessive Compulsive Disorder Therapeutics - Clinical Trials Mapping 54

6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 54

6.2 Clinical Trials by Phase 55

6.3 Clinical Trials by Trial Status 56

6.4 Prominent Sponsors 57

6.5 Top Companies Participating in Obsessive Compulsive Disorder Therapeutics Clinical Trials 59

7 Obsessive Compulsive Disorder Therapeutics - Strategic Assessment 60

7.1 Key Events Impacting the Future Market 60

7.2 Obsessive Compulsive Disorder Therapeutics: Implications for Future Market Competition 61

8 Obsessive Compulsive Disorder Therapeutics - Future Players 62

8.1 Introduction 62

8.2 Company Profiles 63

8.2.1 Transcept Pharmaceuticals, Inc. 63

9 OCD Therapeutics - Appendix 64

9.1 Market Definitions 64

9.2 Abbreviations 64

9.3 Research Methodology 65

9.3.1 Coverage 65

9.3.2 Secondary Research 66

9.3.3 Forecasting 66

9.3.4 Primary Research 69

9.3.5 Expert Panel Validation 69

9.4 Contact Us 69

9.5 Disclaimer 69

9.6 Bibliography 7

List of Tables

1.1 List of Tables

Table 1: Prevalent Pool of Obsessive Compulsive Disorder in Seven Major Markets 8

Table 2: Obsessive Compulsive Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011 19

Table 3: Obsessive Compulsive Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019 20

Table 4: Obsessive Compulsive Disorder Therapeutics Market, The US, Revenue ($m), 2006-2011 21

Table 5: Obsessive Compulsive Disorder Therapeutics Market, The US, Forecasts ($m), 2011-2019 22

Table 6: Obsessive Compulsive Disorder Therapeutics Market, France, Revenue ($m), 2006-2011 23

Table 7: Obsessive Compulsive Disorder Therapeutics Market, France, Forecasts ($m), 2011-2019 24

Table 8: Obsessive Compulsive Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011 25

Table 9: Obsessive Compulsive Disorder Therapeutics Market, Germany, Forecasts ($m), 2011-2019 26

Table 10: Obsessive Compulsive Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011 27

Table 11: Obsessive Compulsive Disorder Therapeutics Market, Italy, Forecasts ($m), 2011-2019 28

Table 12: Obsessive Compulsive Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011 29

Table 13: Obsessive Compulsive Disorder Therapeutics Market, Spain, Forecasts ($m), 2011-2019 30

Table 14: Obsessive Compulsive Disorder Therapeutics Market, The UK, Revenue ($m), 2006-2011 31

Table 15: Obsessive Compulsive Disorder Therapeutics Market, The UK, Forecasts ($m), 2011-2019 32

Table 16: Obsessive Compulsive Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011 33

Table 17: Obsessive Compulsive Disorder Therapeutics Market, Japan, Forecasts ($m), 2011-2019 34

Table 18: Outcome Classification (%) on CGI Global Improvement Item for Study 1 40

Table 19: Outcome Classification (%) on CGI-Global Improvement Item for Completers in Pool of Two Adult Obsessive Compulsive Disorder Studies 42

Table 20: Outcome Classification (%) on CGI Global Improvement Item for Two Obsessive Compulsive Disorder Studies 43

Table 21: Obsessive Compulsive Disorder Therapeutics - Phase III Pipeline, 2012 47

Table 22: Obsessive Compulsive Disorder Therapeutics - Phase II Pipeline, 2012 47

Table 23: Obsessive Compulsive Disorder Therapeutics - Pre-Clinical Pipeline, 2012 48

Table 24: Obsessive Compulsive Disorder Therapeutics - Discovery Pipeline, 2012 48

Table 25: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Country, 2012 54

Table 26: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Phase, 2012 55

Table 27: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Status, 2012 56

Table 28: Obsessive Compulsive Disorder Therapeutics - Prominent Sponsors, 2012 58

Table 29: Obsessive Compulsive Disorder Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012 59

Table 30: Transcept Pharmaceuticals -Pipeline for OCD, 2012 63

List of Figures

1.2 List of Figures

Figure 1: Key Opinion Leader Insights, Prevalence of Obsessive Compulsive Disorder in the US, Germany and Japan 8

Figure 2: Orbito-Subcortical Circuits Pathway Associated with Obsessive Compulsive Disorder 10

Figure 3: Key Opinion Leader Insights, Diagnosis of Obsessive Compulsive Disorder in the US, Germany and Japan 13

Figure 4: Key Opinion Leader Insights, Guidelines for Obsessive Compulsive Disorder in the US, Germany and Japan 14

Figure 5: Key Opinion Leader Insights, Treatment of Obsessive Compulsive Disorder in the US, Germany and Japan 14

Figure 6: Key Opinion Leader Insights, Pharmacological Treatment for Obsessive Compulsive Disorder in the US, Germany and Japan 15

Figure 7: Referral Pathway for Obsessive Compulsive Disorder 17

Figure 8: Key Opinion Leader Insights, Referral Pathway for Obsessive Compulsive Disorder in the US, Germany and Japan 17

Figure 9: Obsessive Compulsive Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011 19

Figure 10: Obsessive Compulsive Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019 20

Figure 11: Obsessive Compulsive Disorder Therapeutics Market, the US, Revenue ($m), 2006-2011 21

Figure 12: Obsessive Compulsive Disorder Therapeutics Market, The US, Forecast ($m), 2011-2019 22

Figure 13: Obsessive Compulsive Disorder Therapeutics Market, France, Revenue ($m), 2006-2011 23

Figure 14: Obsessive Compulsive Disorder Therapeutics Market, France, Forecast ($m), 2011-2019 24

Figure 15: Obsessive Compulsive Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011 25

Figure 16: Obsessive Compulsive Disorder Therapeutics Market, Germany, Forecast ($m), 2011-2019 26

Figure 17: Obsessive Compulsive Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011 27

Figure 18: Obsessive Compulsive Disorder Therapeutics Market, Italy, Forecast ($m), 2011-2019 28

Figure 19: Obsessive Compulsive Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011 29

Figure 20: Obsessive Compulsive Disorder Therapeutics Market, Spain, Forecast ($m), 2011-2019 30

Figure 21: Obsessive Compulsive Disorder Therapeutics Market, The UK, Revenue ($m), 2006-2011 31

Figure 22: Obsessive Compulsive Disorder Therapeutics Market, The UK, Forecast ($m), 2011-2019 32

Figure 23: Obsessive Compulsive Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011 33

Figure 24: Obsessive Compulsive Disorder Therapeutics Market, Japan, Forecast ($m), 2011-2019 34

Figure 25: Key Opinion Leader Insights, Current Unmet Need for Obsessive Compulsive Disorder in the US, Germany and Japan 36

Figure 26: Opportunity and Unmet Need in the Obsessive Compulsive Disorder Therapeutics Market 37

Figure 27: Key Opinion Leader Insights, Limitations with the Currently Available Treatment Options for Obsessive Compulsive Disorder in the US, Germany and Japan 39

Figure 28: Obsessive Compulsive Disorder Therapeutics - Strategic Competitor Assessment, 2011 39

Figure 29: Key Opinion Leader Insights, Research for Future Treatment Options for Obsessive Compulsive Disorder in the US, Germany and Japan 46

Figure 30: Obsessive Compulsive Disorder Therapeutics - Pipeline by Phase of Development, 2012 47

Figure 31: Obsessive Compulsive Disorder Therapeutics - Technology Trends Analytics Framework, 2012 49

Figure 32: Obsessive Compulsive Disorder Therapeutics - Technology Trends Analytics Framework - Description, 2012 50

Figure 33: Obsessive Compulsive Disorder Therapeutics - Pipeline by Mechanism of Action, 2012 51

Figure 34: Clinical Trial Details of Gammunex 52

Figure 35: Clinical Trial Details of TO-2061 (ondansetron) 53

Figure 36: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Country, 2012 54

Figure 37: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Phase, 2012 55

Figure 38: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Status, 2012 56

Figure 39: Obsessive Compulsive Disorder Therapeutics - Overall Sponsors, 2012 57

Figure 40: Obsessive Compulsive Disorder Therapeutics - Prominent Sponsors, 2012 58

Figure 41: Obsessive Compulsive Disorder Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012 59

Figure 42: Obsessive Compulsive Disorder Therapeutics Market, Drivers and Restraints 2011 60

Figure 43: Implications for Future Market Competition in the Obsessive Compulsive Disorder Market, 2011 61

Figure 44: Obsessive Compulsive Disorder Therapeutics Market - Pipeline by Company, 2012 62

Companies Mentioned

Transcept Pharmaceuticals, Inc

To order this report:

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Contact Nicolas: nicolasbombourg@reportlinker.com US: (805)-652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
COPYRIGHT 2012 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:9JAPA
Date:Sep 17, 2012
Words:2772
Previous Article:The Global Naval Vessels MRO Market 2012-2022.
Next Article:Power Brands Reviews Announces Product Recognition.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters